The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate
Impact in
- Molecular Biology 1.1k
- Cancer Research 762
Classified as
- Journal
- Cancer Cell
In The Last Decade
doi.org/10.1016/j.ccr.2010.01.020 →Countries where authors are citing The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate
This map shows the geographic impact of The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate more than expected).
Fields of papers citing The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate
This network shows the impact of The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate.
About The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate
This paper, published in 2010, received 1.7k indexed citations . Written by Patrick S. Ward, Jay L. Patel, David R. Wise, Omar Ibrahim Abdel-Wahab, Bryson D. Bennett, Hilary A. Coller, Justin R. Cross, Valeria R. Fantin, Cyrus V. Hedvat and Alexander E. Perl covering the research area of Cancer Research, Genetics and Hematology. It is primarily cited by scholars working on Molecular Biology (1.1k citations), Cancer Research (762 citations), Hematology (563 citations), Genetics (434 citations) and Oncology (109 citations). Published in Cancer Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
This paper is also available at doi.org/10.1016/j.ccr.2010.01.020.